At Biocon, we are a globally aligned team inspired by a shared vision and strong leadership, united in our mission to transform global health. By delivering safe, effective, and high-quality biosimilars and generics, we are committed to expanding equitable access to essential medicines for patients everywhere. As we navigate a complex healthcare landscape, we harness our scientific depth and technological strength to drive progress and evolve into a leading global innovator in healthcare. Every step we take is guided by our dedication to driving positive social and environmentally sustainable impact that contributes to a healthier world.

Biocon’s fully integrated lab-to-patient model empowers us to deliver critical medicines swiftly and reliably across 120+ countries. By collaborating with partners and healthcare systems and leveraging our global scale, we expand patient access efficiently. Our investment in end-to-end capabilities—from R&D to manufacturing to commercialization—ensures a seamless experience and a resilient supply chain. With manufacturing sites across multiple geographies, we operate with agility, responsiveness, and flexibility. Bold decisions, like the Viatris acquisition, reflect our commitment to challenging conventional paths and earning stakeholder trust through consistent delivery and innovation.

In an environment where pricing and access remain key challenges, Biocon plays a pivotal role by providing high-quality biosimilars and generics to treat serious conditions like diabetes, cancer, obesity, and autoimmune diseases.

Our deep expertise across generics and biosimilars empowers us to meet evolving market needs. United by a shared purpose and driven by the courage to lead, we are working toward a bold ambition: to reach a billion patients with affordable, life-changing medicines.

We are committed to maintaining the highest quality standards. Our regulatory and quality systems are robust, best-in-class and of global standards. They have earned us the trust of patients, doctors, caregivers, partners and healthcare ecosystems around the world.

We believe that real, sustainable growth is possible when industry interests are balanced with societal interests. We aim to make a difference by changing the healthcare dynamics and making high-quality, affordable medicine accessible to more than a billion people. Our strong sense of ethics drives us in creating long-term value for all our stakeholders.

Our people are our biggest asset. They fuel innovation in our pipeline and hold true to our commitment of exploring the unexplored in medicine. Our deep-rooted entrepreneurial culture attracts the brightest talent. We strive to maintain an environment that values our diverse workforce, constantly motivating them to realise their full potential.